WOUND EVISCERATION side effect
What is WOUND EVISCERATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
WOUND EVISCERATION and Recently Reported Side Effects
WOUND EVISCERATION and 15 most Active Side Effect polls
WOUND EVISCERATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Taxotere Side Effects Report #5598362-5
Health Professional from UNITED STATES reported TAXOTERE problem on Jan 10, 2008. Female patient, 53 years of age, weighting 155.0 lb, was diagnosed with ovarian cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: wound evisceration, . TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN, BEVACIZUMAB, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5775102-8
ERLOTINIB problem was reported by a Consumer or non-health professional from UNITED STATES on May 28, 2008. Male patient, 63 years of age, weighting 201.9 lb, was diagnosed with oesophageal carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: wound evisceration, . ERLOTINIB dosage: (100 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5736863-7
Health Professional from UNITED STATES reported BEVACIZUMAB problem on May 07, 2008. Male patient, weighting 202.0 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: wound evisceration, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5750248-9
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on May 21, 2008. Male patient, weighting 202.0 lb, was diagnosed with oesophageal carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: wound evisceration, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5262707-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 05, 2007. Female patient, weighting 155.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: wound evisceration, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient recovered.
Erlotinib Side Effects Report #5756956-8
ERLOTINIB problem was reported by a Physician from UNITED STATES on May 14, 2008. Male patient, 63 years of age, weighting 201.9 lb, was diagnosed with oesophageal carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: post procedural complication, wound evisceration, . ERLOTINIB dosage: (100 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Cisplatin Side Effects Report #5261940-7
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2007. Female patient, 63 years of age, was diagnosed with ovarian cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: vaginal discharge, wound evisceration, . CISPLATIN dosage: 85 MG/M2 DAILY IP. During the same period patient was treated with PACLITAXEL, DOCETAXEL. Patient was hospitalized. Patient recovered.
Cisplatin Side Effects Report #5267020-9
CISPLATIN problem was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 63 years of age, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: vaginal disorder, wound evisceration, . CISPLATIN dosage: (85 MG/M2, ONCE ON POSTOPERATIVE DAY 13) INTRAPERITONEAL. During the same period patient was treated with DOCETAXEL, PACLITAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5595942-8
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 14, 2008. Female patient, weighting 155.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, impaired healing, wound evisceration, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Taxotere Side Effects Report #5266118-9
TAXOTERE problem was reported by a Health Professional from UNITED STATES on Mar 05, 2007. Female patient, 53 years of age, weighting 155.0 lb, was diagnosed with ovarian cancer and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, impaired healing, wound evisceration, . TAXOTERE dosage: unknown. During the same period patient was treated with OXALIPLATIN, BEVACIZUMAB. Patient recovered.